Pharmacology and pharmacokinetics of 5-aminosalicylic acid

Digestive Diseases and Sciences
U Klotz, K Maier

Abstract

There is accumulating clinical evidence that 5-aminosalicylic acid (5-ASA), a primary metabolite of sulfasalazine (SAS), represents the therapeutic active moiety of the azo-compound SAS in the treatment of chronic inflammatory bowel disease (IBD). Since it is presumed that 5-ASA acts from the lumen of the intestine, it is important to know how much 5-ASA is released from its special galenic formulations. After liberation of 5-ASA in the terminal ileum (only slow release oral preparations of 5-ASA) and colon (5-ASA suppositories and enemas), 5-ASA is only partly absorbed. A major part of this 5-ASA is presystemically eliminated, eg, N-acetylated during its first passage through the intestinal mucosa and liver. Mean steady state plasma levels of unchanged 5-ASA are rather low (range 0.02 to 1.2 microgram/ml) whereas those of Ac-5-ASA are always higher (range 0.1 to 2.9 micrograms/ml). This is due to the rapid elimination of 5-ASA (t1/2 = 0.4 to 2.4h) and the slightly slower renal excretion of the Ac-5-ASA (t1/2 = 6 to 9 h, renal clearance = 200 to 300 ml/min). The knowledge of the pharmacokinetic properties of 5-ASA from different drug formulations might contribute to a better understanding of its mode of action in IBD.

References

Jul 23, 1982·Deutsche medizinische Wochenschrift·K MaierK Heinkel
Aug 1, 1983·British Journal of Clinical Pharmacology·M J DewJ Rhodes

❮ Previous
Next ❯

Citations

Aug 16, 2008·European Journal of Clinical Pharmacology·Hendrik LückFritz Sörgel
Mar 20, 1998·Advances in Internal Medicine·S J Bickston, F Cominelli
Sep 1, 1990·Digestive Diseases and Sciences·M T FiorentiniM de la Pierre
Sep 17, 2013·World Journal of Gastroenterology : WJG·Renata D'IncàGiacomo Carlo Sturniolo
Apr 29, 1999·Drug Development and Industrial Pharmacy·Y S KrishnaiahY V Prasad
Sep 2, 2015·European Journal of Pharmacology·Raquel Cristina SchwankeJoão B Calixto
Oct 22, 2005·Inflammatory Bowel Diseases·D J de JongA H J Naber
Nov 5, 2015·Inflammatory Bowel Diseases·Arvind I SrinathSohail Z Husain
Nov 24, 2011·Case Reports in Gastroenterology·Yoshinori AraiHisao Tajiri
Mar 8, 2018·Clinical Pharmacokinetics·Luc J J DerijksAdriaan A van Bodegraven
Nov 11, 1989·BMJ : British Medical Journal·J A Hewitt, J Glinn
Nov 11, 1989·BMJ : British Medical Journal·D K Woodward
Jan 21, 2010·Journal of Clinical Gastroenterology·C S PitchumoniKiron Das
Nov 15, 2001·Clinical Pharmacokinetics·M Schwab, U Klotz
Jan 1, 1990·Scandinavian Journal of Gastroenterology. Supplement·H P Osterwald
May 27, 2015·European Journal of Clinical Pharmacology·E G QuetglasSilvio Danese
Apr 1, 1992·Clinical and Experimental Immunology·W E Pullman, W F Doe
May 13, 2018·Clinical Pharmacokinetics·Sophie E BerendsRon A A Mathôt
Jul 1, 1990·The Journal of Pharmacy and Pharmacology·E O AdeyemiH J Hodgson
Dec 1, 1989·DICP : the Annals of Pharmacotherapy·R F SottileB Mehl
Feb 1, 1991·DICP : the Annals of Pharmacotherapy·J M Fitzgerald, T D Marsh
Oct 18, 2006·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Areena SwarupH Ralph Schumacher
Aug 24, 1999·International Journal of Pancreatology : Official Journal of the International Association of Pancreatology·E AdachiT Chiba

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacology and Therapeutics
A CuadradoJ L Pedraz
Arzneimittel-Forschung
Emil GatchevChristian de Mey
Journal of Clinical Pharmacy and Therapeutics
M Sheikh SalemM S Shubair
© 2021 Meta ULC. All rights reserved